Spots Global Cancer Trial Database for placebos
Every month we try and update this database with for placebos cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention | NCT04375813 | Non-muscle Inva... | eRapa Placebos | 18 Years - | Rapamycin Holdings Inc. | |
| Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients | NCT04227522 | Ovarian Cancer Fallopian Tube ... Primary Periton... Clear Cell Carc... | Rucaparib Placebos | 18 Years - | North Eastern German Society of Gynaecological Oncology | |
| the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation | NCT03483142 | Myoma;Uterus Blood Loss | Misoprostol Placebos | 25 Years - 50 Years | Ain Shams Maternity Hospital | |
| A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer | NCT04139135 | Gastric Cancer | HLX10 Placebos | 18 Years - 70 Years | Shanghai Henlius Biotech | |
| Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC | NCT03607539 | Lung Neoplasms | Sintilimab Pemetrexed Platinum Placebos | 18 Years - 75 Years | Innovent Biologics (Suzhou) Co. Ltd. | |
| From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1 | NCT03826940 | Autism Spectrum... Neurofibromatos... | Lovastatin 60 M... Placebos | 16 Years - 65 Years | University of Coimbra | |
| Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | NCT03175341 | Breast Cancer | Ascorbic Acid Placebos | 18 Years - | Academic Emergency County Hospital Sibiu | |
| Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial | NCT04099901 | Multiple Myelom... | Anakinra Placebos | 18 Years - | Radboud University Medical Center | |
| Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients | NCT00002445 | Sarcoma, Kaposi HIV Infections | IM862 | 18 Years - | NIH AIDS Clinical Trials Information Service | |
| Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant | NCT03447132 | Breast Neoplasm... | Fulvestrant 500... Palbociclib 125... Goserelin 3.6 M... Placebos | 18 Years - | International Cancer Research Group, United Arab Emirates | |
| Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC | NCT03614065 | Non-small Cell ... | endostar Placebos radiotherapy | 18 Years - 70 Years | Wuhan Union Hospital, China | |
| Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines | NCT03622931 | Ovarian Cancer | Standard chemot... Romiplostim Placebos | 18 Years - | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | |
| Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention | NCT04375813 | Non-muscle Inva... | eRapa Placebos | 18 Years - | Rapamycin Holdings Inc. | |
| HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | NCT03780049 | Hepatocellular ... | HAIC of FOLFOX H101 Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy | NCT00245518 | Hot Flashes | Isoflavone Placebos | 21 Years - | Johns Hopkins University | |
| Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial | NCT04099901 | Multiple Myelom... | Anakinra Placebos | 18 Years - | Radboud University Medical Center | |
| A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients | NCT04346888 | Myasthenia Grav... | HBM9161 Injecti... Placebos HBM9161 Injecti... | 18 Years - 99 Years | Harbour BioMed (Guangzhou) Co. Ltd. | |
| The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction | NCT03212625 | Hepatocellular ... | Urea Cream 20% Placebos | - | Korea University Guro Hospital | |
| Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer | NCT04073550 | Small Cell Lung... | Anlotinib Placebos Topotecan | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) | NCT03980041 | Bladder Cancer Urothelial Carc... Solid Tumor Advanced Cancer | IPI-549 (eganel... Nivolumab Placebos | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients | NCT04227522 | Ovarian Cancer Fallopian Tube ... Primary Periton... Clear Cell Carc... | Rucaparib Placebos | 18 Years - | North Eastern German Society of Gynaecological Oncology | |
| A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC) | NCT03958890 | Esophageal Squa... | HLX10 100 mg in... Placebos | 18 Years - 75 Years | Shanghai Henlius Biotech | |
| Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer | NCT03117335 | Advanced Non-sm... | Placebos Sulijia | 18 Years - 70 Years | Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. | |
| Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies | NCT04311073 | Fibroid Uterus Abnormal Uterin... Myoma;Uterus | Tranexamic Acid Placebos | 18 Years - 45 Years | Eastern Virginia Medical School | |
| Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients | NCT03847311 | Breast Cancer Chronic Pain Du... | Sulfasalazine Placebos | 18 Years - 94 Years | University of Arizona | |
| Muscadine Plus (MPX) In Men With Prostate Cancer | NCT03535675 | Adenocarcinoma ... | Muscadine Plus Placebos | 18 Years - 99 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer | NCT03175341 | Breast Cancer | Ascorbic Acid Placebos | 18 Years - | Academic Emergency County Hospital Sibiu | |
| A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular Invasion | NCT04255771 | Chemotherapy Ef... | Gemcitabine Placebos | 20 Years - 85 Years | Shandong Provincial Hospital | |
| The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction | NCT03212625 | Hepatocellular ... | Urea Cream 20% Placebos | - | Korea University Guro Hospital | |
| Effect of IV Infusion of Lidocaine Compared to IV Infusion of Dexmedetomidine on Proinflammatory Cytokines | NCT04148599 | Inflammatory Re... | dexmedetomidine... lidocaine infus... Placebos | 18 Years - 60 Years | National Cancer Institute, Egypt | |
| TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC | NCT03782831 | Hepatocellular ... | TACE PD-1 antibody Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| Broccoli Sprout Dose Response: Bioavailability and Effects of Air Pollutants | NCT02656420 | Environmental C... | Broccoli Sprout... Placebos | 21 Years - 65 Years | Johns Hopkins Bloomberg School of Public Health | |
| Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery | NCT03216187 | Persistent Post... | Pregabalin Placebos | 18 Years - | University Hospital, Geneva | |
| Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer | NCT04168346 | Gastric Cancer Anemia Surgery Iron Deficiency... Surgery--Compli... | Ferric carboxym... Placebos | 18 Years - | Helsinki University Central Hospital | |
| A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC) | NCT03958890 | Esophageal Squa... | HLX10 100 mg in... Placebos | 18 Years - 75 Years | Shanghai Henlius Biotech | |
| Study of Testosterone vs Placebo in Testicular Cancer Survivors | NCT02991209 | Metabolic Syndr... Testicular Canc... Leydig Cell Fai... | Testosterone Placebos | 18 Years - 65 Years | Rigshospitalet, Denmark | |
| Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer | NCT03117335 | Advanced Non-sm... | Placebos Sulijia | 18 Years - 70 Years | Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. | |
| Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients | NCT04227522 | Ovarian Cancer Fallopian Tube ... Primary Periton... Clear Cell Carc... | Rucaparib Placebos | 18 Years - | North Eastern German Society of Gynaecological Oncology | |
| Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. | NCT03144843 | Gastric Cancer | Apatinib Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer | NCT03353831 | Recurrent Ovari... | Bevacizumab Atezolizumab Chemotherapy Placebos | 18 Years - | AGO Research GmbH | |
| Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). | NCT01682083 | Melanoma | Dabrafenib Trametinib Placebos | 18 Years - | Novartis | |
| Effect of Vitamin C in Autologous Stem Cell Transplantations | NCT03964688 | Myeloma Multipl... Lymphoma | Vitamin C Placebos | 18 Years - | Maastricht University Medical Center | |
| the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation | NCT03483142 | Myoma;Uterus Blood Loss | Misoprostol Placebos | 25 Years - 50 Years | Ain Shams Maternity Hospital | |
| Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer | NCT03262545 | Angiogenesis In... | apatinib Placebos | 18 Years - 70 Years | Sichuan Cancer Hospital and Research Institute | |
| Effect of IV Infusion of Lidocaine Compared to IV Infusion of Dexmedetomidine on Proinflammatory Cytokines | NCT04148599 | Inflammatory Re... | dexmedetomidine... lidocaine infus... Placebos | 18 Years - 60 Years | National Cancer Institute, Egypt | |
| Effects of Probiotics in Preventing Oral Mucositis | NCT03552458 | Head-and-neck C... | Lactobacillus R... Placebos | 21 Years - 99 Years | National University Hospital, Singapore | |
| HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | NCT03780049 | Hepatocellular ... | HAIC of FOLFOX H101 Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer | NCT04168346 | Gastric Cancer Anemia Surgery Iron Deficiency... Surgery--Compli... | Ferric carboxym... Placebos | 18 Years - | Helsinki University Central Hospital | |
| Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC | NCT03607539 | Lung Neoplasms | Sintilimab Pemetrexed Platinum Placebos | 18 Years - 75 Years | Innovent Biologics (Suzhou) Co. Ltd. | |
| Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer | NCT00022399 | Prostate Cancer | celecoxib Placebos | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer | NCT03581786 | Recurrent or Me... | TORIPALIMAB INJ... Placebos | 18 Years - 75 Years | Shanghai Junshi Bioscience Co., Ltd. | |
| Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial | NCT04099901 | Multiple Myelom... | Anakinra Placebos | 18 Years - | Radboud University Medical Center | |
| Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer | NCT03817411 | Gastric Cancer | Telatinib Capecitabine Oxaliplatin Placebos | 18 Years - 75 Years | Taizhou EOC Pharma Co., Ltd. | |
| A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer | NCT04139135 | Gastric Cancer | HLX10 Placebos | 18 Years - 70 Years | Shanghai Henlius Biotech | |
| Dexmedetomidine and HIPEC | NCT04106999 | Inflammation Cancer | Dexmedetomidine Placebos | 18 Years - 99 Years | University of British Columbia | |
| Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. | NCT03144843 | Gastric Cancer | Apatinib Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer | NCT03581786 | Recurrent or Me... | TORIPALIMAB INJ... Placebos | 18 Years - 75 Years | Shanghai Junshi Bioscience Co., Ltd. | |
| Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy | NCT03821454 | Breast Cancer | Capecitabine Placebos | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer | NCT03571126 | Chemotherapy-in... Lung Cancer | Olanzapine Placebos | 18 Years - 70 Years | Zunyi Medical College | |
| The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction | NCT03212625 | Hepatocellular ... | Urea Cream 20% Placebos | - | Korea University Guro Hospital | |
| Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma | NCT03707509 | Nasopharyngeal ... | Camrelizumab Placebos Gemcitabine Cisplatin | 18 Years - 75 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). | NCT01682083 | Melanoma | Dabrafenib Trametinib Placebos | 18 Years - | Novartis | |
| A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer | NCT04169997 | Ovarian Cancer | IMP4927 Placebos | 18 Years - | Impact Therapeutics, Inc. | |
| From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1 | NCT03826940 | Autism Spectrum... Neurofibromatos... | Lovastatin 60 M... Placebos | 16 Years - 65 Years | University of Coimbra | |
| Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer | NCT03716583 | Radiation Derma... Radiation Derma... Breast Cancer | Melatonin Dimethyl Sulfox... Placebos | 50 Years - | Herlev Hospital | |
| Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer | NCT03716583 | Radiation Derma... Radiation Derma... Breast Cancer | Melatonin Dimethyl Sulfox... Placebos | 50 Years - | Herlev Hospital | |
| CH1701 for Prevention and Treatment of Radiation Burns | NCT04386343 | Cancer | CH1701 for prev... Safety assessme... Placebos | 18 Years - 60 Years | Vietlife Healthcare Corporation | |
| Atezolizumab Trial in Endometrial Cancer - AtTEnd | NCT03603184 | Endometrial Can... | Atezolizumab Placebos Paclitaxel Carboplatin | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| CH1701 for Prevention and Treatment of Radiation Burns | NCT04386343 | Cancer | CH1701 for prev... Safety assessme... Placebos | 18 Years - 60 Years | Vietlife Healthcare Corporation | |
| Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer | NCT03571126 | Chemotherapy-in... Lung Cancer | Olanzapine Placebos | 18 Years - 70 Years | Zunyi Medical College | |
| Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient | NCT03705156 | Platinum-sensit... | ZL-2306(nirapai... Placebos | 18 Years - | Zai Lab (Hong Kong), Ltd. | |
| From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1 | NCT03826940 | Autism Spectrum... Neurofibromatos... | Lovastatin 60 M... Placebos | 16 Years - 65 Years | University of Coimbra |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
